Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience

被引:0
作者
Izabela Kupryś-Lipińska
Paweł Majak
Joanna Molinska
Piotr Kuna
机构
[1] Barlicki University Hospital,Department of Internal Medicine, Asthma and Allergy
[2] Medical University of Lodz,undefined
来源
BMC Pulmonary Medicine | / 16卷
关键词
Effectiveness; Omalizumab; Severe asthma; Severe asthma exacerbations;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] 'Real-world' effectiveness of omalizumab in adults with severe allergic asthma: a meta-analysis
    Faulkner, Kenneth M.
    MacDonald, Karen
    Abraham, Ivo
    Alhossan, Abdulaziz
    Lee, Christopher S.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (01) : 73 - 83
  • [22] "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
    Brusselle, G.
    Michils, A.
    Louis, R.
    Dupont, L.
    de Maele, B. Van
    Delobbe, A.
    Pilette, C.
    Lee, C. S.
    Gurdain, S.
    Vancayzeele, S.
    Lecomte, P.
    Hermans, C.
    MacDonald, K.
    Song, M.
    Abraham, I.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1633 - 1642
  • [23] Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
    Sullivan, Patrick W.
    Li, Qianyi
    Bilir, S. Pinar
    Dang, Joseph
    Kavati, Abhishek
    Yang, Ming
    Rajput, Yamina
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 23 - 32
  • [24] Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma
    Frix, A. N.
    Schleich, F.
    Paulus, V
    Guissard, F.
    Henket, M.
    Louis, R.
    BIOCHEMICAL PHARMACOLOGY, 2020, 179
  • [25] Mepolizumab in Severe Pediatric Asthma: Certainties and Doubts through a Single-Center Experience and Review of the Literature
    Maglione, Marco
    Borrelli, Melissa
    Dorato, Alessandro
    Cimbalo, Chiara
    del Giudice, Luigi Antonio
    Santamaria, Francesca
    CHILDREN-BASEL, 2024, 11 (08):
  • [26] Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD
    Maltby, Steven
    Gibson, Peter G.
    Powell, Heather
    McDonald, Vanessa M.
    CHEST, 2017, 151 (01) : 78 - 89
  • [27] Successful treatment of severe allergic asthma with omalizumab in a girl with DiGeorge syndrome
    Jesenak, Milos
    Zelieskova, Maria
    Repko, Miroslav
    Banovcin, Peter
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 45 (03) : 361 - 363
  • [28] Severe allergic asthma: Does alexithymia interfere with omalizumab treatment outcome?
    Liotta, Marta
    Liotta, Marco
    Saitta, Salvatore
    Ricciardi, Luisa
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2023, 41 (01) : 53 - 59
  • [29] The Long-Term Effectiveness of Omalizumab in Adult Patients with Severe Allergic Asthma: Continuous Treatment Versus Boosting Treatment
    Huang, Wei-Chang
    Fu, Pin-Kuei
    Chan, Ming-Cheng
    Chin, Chun-Shih
    Huang, Wen-Nan
    Lai, Kuo-Lung
    Wang, Jiun-Long
    Hung, Wei-Ting
    Wu, Yi-Da
    Hsieh, Chia-Wei
    Wu, Ming-Feng
    Chen, Yi-Hsing
    Hsu, Jeng-Yuan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 11
  • [30] Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study
    Numata, Takanori
    Araya, Jun
    Miyagawa, Hanae
    Okuda, Keitaro
    Fujita, Yu
    Utsumi, Hirofumi
    Takekoshi, Daisuke
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Kuwano, Kazuyoshi
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 609 - 618